This article is primarily concerned with treatment but it is necessary to make brief reference to the selection of patients who should be treated. The views expressed are based on the experience gained in running a special clinic for hypertensive patients over the past ten years since the introduction of potent hypertensive drugs and are the result of much discussion with those concerned.
None will doubt the magnitude of the problem or the fact that, potentially, high blood pressure is a serious condition. The modern dilemma lies in the fact that much can now be done to relieve symptoms, to prevent or postpone complications and to prolong life, but treatment is beset with difficulties and usually must be continued for life. As yet no really satisfactory drug has been produced. In our experience, few patients with hypertension feel ill. They may be troubled with visual, cerebral or cardiac symptoms, but on the whole they do not suffer from malaise. By contrast, few patients on treatment with hypotensive drugs feel really well. They may be grateful for the relief of symptoms such as those mentioned above but if, for any reason, treatment has to be stopped or should they inadvertently run short of tablets, an unmistakable sensation of relative well being is noticed. Treatment entails frequent medical attention and the daily taking of potent remedies which often have unpleasant side effects. It is our impression that many patients are having treatment which is unwarranted and many others who are in the need of the best that can be offered are receiving treatment which is inadequate.
In most cases it is not considered advisable for treatment to be begun without prior assessmentin hospital, and it is believed that a special clinic offers the best means of helping the practitioner to maintain good management thereafter.
Time and facilities are needed to ensure that there is no underlying disease which may require special treatment or which should at least be recognised, to assess the severity of the hypertension itself, the degree of secondary effects in the retinae, brain, heart and kidneys and the degree of disease from associated atheroma, and also to initiate appropriate treatment which then can be continued by the practitioner in association with the clinic. 
